View in EDS

Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer.

Saved in:
Bibliographic Details
Title: Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer.
Authors: Salvatore L; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy., Fakih M; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA., Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Hong DS; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, University of Texas, Houston, TX., Modest DP; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Taieb J; Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, Université Paris-Cité, SIRIC CARPEM, Paris, France., Price TJ; Queen Elizabeth Hospital, University of Adelaide, Adelaide, SA, Australia., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Majer IM; Health Economics and Outcomes Research, Amgen (Europe) GmbH, Rotkreuz, Switzerland. Electronic address: imajer@amgen.com., Rehn M; Global Medical Organization, Amgen Inc., Thousand Oaks, CA., Chan E; Global Development, Amgen Inc., Thousand Oaks, CA., Chen Z; Health Economic and Outcomes Research, Amgen Inc., Tampa, FL., Tran Q; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2026 Apr 23. Date of Electronic Publication: 2026 Apr 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42173791
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Salvatore+L%22">Salvatore L</searchLink>; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Fakih+M%22">Fakih M</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Kuboki+Y%22">Kuboki Y</searchLink>; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Hong+DS%22">Hong DS</searchLink>; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, University of Texas, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Modest+DP%22">Modest DP</searchLink>; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Taieb+J%22">Taieb J</searchLink>; Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, Université Paris-Cité, SIRIC CARPEM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Price+TJ%22">Price TJ</searchLink>; Queen Elizabeth Hospital, University of Adelaide, Adelaide, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Cremolini+C%22">Cremolini C</searchLink>; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Majer+IM%22">Majer IM</searchLink>; Health Economics and Outcomes Research, Amgen (Europe) GmbH, Rotkreuz, Switzerland. Electronic address: imajer@amgen.com.<br /><searchLink fieldCode="AU" term="%22Rehn+M%22">Rehn M</searchLink>; Global Medical Organization, Amgen Inc., Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Chan+E%22">Chan E</searchLink>; Global Development, Amgen Inc., Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Health Economic and Outcomes Research, Amgen Inc., Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Tran+Q%22">Tran Q</searchLink>; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA.<br /><searchLink fieldCode="AU" term="%22Pietrantonio+F%22">Pietrantonio F</searchLink>; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101120693%22">Clinical colorectal cancer</searchLink> [Clin Colorectal Cancer] 2026 Apr 23. <i>Date of Electronic Publication: </i>2026 Apr 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101120693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215330028%22">15330028 </searchLink><i>NLM ISO Abbreviation: </i>Clin Colorectal Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42173791
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clcc.2026.04.003
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Salvatore L
      – PersonEntity:
          Name:
            NameFull: Fakih M
      – PersonEntity:
          Name:
            NameFull: Kuboki Y
      – PersonEntity:
          Name:
            NameFull: Hong DS
      – PersonEntity:
          Name:
            NameFull: Modest DP
      – PersonEntity:
          Name:
            NameFull: Taieb J
      – PersonEntity:
          Name:
            NameFull: Price TJ
      – PersonEntity:
          Name:
            NameFull: Cremolini C
      – PersonEntity:
          Name:
            NameFull: Majer IM
      – PersonEntity:
          Name:
            NameFull: Rehn M
      – PersonEntity:
          Name:
            NameFull: Chan E
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Tran Q
      – PersonEntity:
          Name:
            NameFull: Pietrantonio F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 04
              Text: 2026 Apr 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0674
          Titles:
            – TitleFull: Clinical colorectal cancer
              Type: main
ResultId 1